News

Leerink notes that Moderna’s strengthened solvency could intensify the IP dispute, leaving legal and royalty outcomes as a continuing risk. Consequently, analysts focus on the 2026 batoclimab catalyst as the central lever for potential upside. The long‑term revenue growth and net profit margin inputs remain unchanged, while the projected future P/E...

Full article

Roivant Sciences’ valuation model remains anchored at a $27.0 per‑share fair value, but the required return has risen to a discount rate of 7.54%, tightening the price target narrative. The shift follows the rescheduling of batoclimab Phase 3 readouts to 2026 and the persistence of litigation over Moderna royalties. Analysts such as Citi’s Samantha...

Full article

Encompass Health (EHC) shares surged after the company reported fourth‑quarter results that beat Wall Street expectations and issued 2026 earnings and revenue guidance above prior analyst forecasts. The stock has posted a 1‑year total shareholder return of 6.21%, a 3‑year return of 75.81%, and a 5‑year return of 69.80%. In the short term, share pri...

Full article

Carlyle Group’s Q4 2025 results highlighted a mixed performance: revenue and net income fell short of the prior year, yet the firm posted record fee‑related earnings driven by strong activity on its Global Credit and AlpInvest platforms. Fund‑raising inflows were robust, with the firm attracting new commitments that offset the dip in earnings.

Full article

CFT remains one of the world’s largest interdealer brokers, operating in over 30 countries with more than 2,500 employees. The Group offers broking and data services across a full spectrum of financial products, including money‑market products, bonds, interest‑rate, currency and credit derivatives, equities, equity derivatives, interest‑rate future...

Full article

In the fourth quarter of 2025, revenue grew 11.7 % at constant exchange rates, reaching CHF 293.2 million compared with CHF 283.5 million in the same period of 2024. Both the interdealer broking (IDB) business and retail (Non‑IDB) segments supplied the growth.

Full article

Compagnie Financière Tradition SA (CFT) reported revenue of CHF 1,203.6 million for the financial year 2025, an 11.4 % increase at constant exchange rates versus the previous year. The rise was driven by higher transaction volumes across all asset classes and regions, as investors reassessed portfolios in response to changing macroeconomic conditio...

Full article

Market data cited in the announcement notes that 85 % of organizations report a surge in mobile attacks and 43 % identify mobile‑app threats as the primary cause of breaches, underscoring the urgency of comprehensive protection. Guardsquare’s integration of XTD aligns with its ongoing M&A strategy to enhance the platform, increase customer reach, a...

Full article

The acquisition strengthens Guardsquare’s global footprint and broadens its industry reach, particularly in financial services and healthcare. Verimatrix’s team of engineers and security specialists will join Guardsquare, accelerating platform evolution. Existing XTD customers will experience seamless continuity, with no disruption to services or s...

Full article

Guardsquare has completed its acquisition of Verimatrix’s Extended Threat Defense (XTD) technology and associated assets. The deal expands Guardsquare’s mobile‑app security platform, adding XTD’s capability to predict, detect, and respond to threats before exploitation and enhancing existing features such as automated testing, multi‑layered protect...

Full article